NASDAQ · Health Information Services · USD
Definitive Healthcare Corp. (DH) Stock Analysis
Definitive Healthcare Corp. (DH) is a Health Information Services stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
DH Key Statistics
As of Oct 21, 2026Trading
- Open
- $1.12
- Previous Close
- $1.13
- Day's Range
- 1.09–1.16
- 52-Week Range
- 0.61–3.02
- Volume
- 288.67K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 1.40
Valuation
- Market Cap
- $122.76M
- P/E Ratio
- unprofitable
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 6.16
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.53
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −1.61
Financials (FY)
- Revenue (FY)
- $241.52M−4.24%
- Net Income (FY)
- −$138.93M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −72.28%
- Shares Outstanding
- 106.74M
- 1-Year Return
- −61.28%
Dividend and dates
- Earnings Date
- November 5, 2026estimated
- Avg Volume
- 604.63K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, DH closed at $1.15, −61.28% over 1 year.
Definitive Healthcare Corp. (DH) has a market capitalization of $122.76M.
In fiscal 2025, DH reported revenue of $241.52M.
DH Stock Return by Calendar Year
Definitive Healthcare Corp. (DH) return since Sep 2021: what $10,000 became
- 1 year
- $10,000 $3,872
- −61.28%
- 5 years
- $10,000 $288
- −97.12%
- Since Sep 2021
- $10,000 $266
- −97.34%
If you had invested $10,000 in Definitive Healthcare Corp. (DH) at the close on September 15, 2021, the earliest close on record here, it would have been worth $266 at the close on October 21, 2026: −97.34% in total, −50.92% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −59.93% |
| 2025 | −30.17% |
| 2024 | −58.65% |
| 2023 | −9.55% |
| 2022 | −59.79% |
| 2021 (partial year) | −36.87% |
As of October 21, 2026.
DH Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $241.52M | −$138.93M | −57.5% |
| 2024 | $252.20M | −$413.12M | −163.8% |
| 2023 | $251.42M | −$202.39M | −80.5% |
| 2022 | $222.65M | −$7.22M | −3.2% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $241.52M | $183.28M | −$20.58M | −$138.93M | −57.5% |
| 2024 | $252.20M | $197.47M | −$9.74M | −$413.12M | −163.8% |
| 2023 | $251.42M | $203.93M | −$30.91M | −$202.39M | −80.5% |
| 2022 | $222.65M | $180.03M | −$36.15M | −$7.22M | −3.2% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
DH Valuation vs Health Information Services Median
Median of 44 stocks| Metric | DH | Health Information Services median | vs median |
|---|---|---|---|
| P/S ratio | 0.53 | 2.31 | 0.2x the median |
| Profit margin | −72.28% | −7.55% | 64.7 pts below |
Medians across 44 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing
YahooDefinitive Healthcare Shares Rise 13% After Advent International Submits $1.02-Per-Share Proposal
InvestorsHubSpecial Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International
YahooDefinitive Healthcare Appoints Clay Ritchey as CEO
YahooDefinitive Healthcare Appoints Clay Ritchey CEO, Effective Sept. 8, Succeeding Kevin Coop
BenzingaDefinitive Healthcare Corp. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlpha
All 11 articles ↓Show fewer ↑
Morgan Stanley Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $1.5
BenzingaDefinitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript
SeekingAlphaDefinitive Healthcare Raises FY2026 Adj EPS Guidance from $0.16-$0.19 to $0.18-$0.20 vs $0.18 Est; Narrows FY2026 Sales Guidance from $220.000M-$226.000M to $220.000M-$222.000M vs $223.449M Est
BenzingaDefinitive Healthcare Sees Q3 Adj EPS $0.04-$0.05 vs $0.04 Est; Sees Sales $54.000M-$55.000M vs $55.542M Est
BenzingaDefinitive Healthcare Q2 Adj. EPS $0.05 Beats $0.04 Estimate, Sales $55.195M Miss $55.476M Estimate
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Health Information Services Stocks
Veeva Systems Inc.
$51.90B
BTSGBrightSpring Health Services, Inc.
$12.40B
TEMTempus AI, Inc.
$12.23B
HNGEHinge Health, Inc.
$9.04B
HQYHealthEquity, Inc.
$8.10B
DOCSDoximity, Inc.
$5.99B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B








